Accuray (ARAY) Beats Q4 Revenue Estimates, BTIG Maintains Buy Rating
Accuray Incorporated (NASDAQ:ARAY) ranks among the top robotics to buy according to analysts. After Accuray Incorporated (NASDAQ:ARAY) reported fiscal fourth-quarter results and fiscal 2026 outlook, BTIG maintained its Buy rating on the radiation therapy company and increased its price target from $4 to $5 on August 14. Accuray’s fiscal fourth-quarter revenue of $127.5 million exceeded […]